 LONDON and NEW YORK, Dec. 08, 2022 GLOBE NEWSWIRE MeiraGTx Holdings plc NASDAQ: MGTX, a vertically integrated, clinical stage gene therapy company, today announced it will host a conference call and webcast to present clinical data from the Companys AAV-hAQP1 Phase 1 AQUAx clinical trial for the treatment of radiation-induced xerostomia RIX on Tuesday, December 13, 2022, at ... The post MeiraGTx to Present Clinical Data from Phase 1 Trial of AAV-hAQP1 for Radiation-Induced Xerostomia on... 